Also developed in 2005 is a condom treated with an erectogenic compound . The drug @-@ treated condom is intended to help the wearer maintain his erection , which should also help reduce slippage . If approved , the condom would be marketed under the Durex brand . As of 2007 , it was still in clinical trials . In 2009 , Ansell Healthcare , the makers of Lifestyle condoms , introduced the X2 condom lubricated with " Excite Gel " which contain the amino acid l @-@ arginine and is intended to improve the strength of the erectile response .